These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26761268)

  • 1. HIV-Specific CD8+ T Cell-Mediated Viral Suppression Correlates With the Expression of CD57.
    Jensen SS; Tingstedt JL; Larsen TK; Brandt L; Gerstoft J; Kronborg G; Pedersen C; Fomsgaard A; Karlsson I
    J Acquir Immune Defic Syndr; 2016 Jan; 71(1):8-16. PubMed ID: 26761268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-2 production by polyfunctional HIV-1-specific CD8 T cells is associated with enhanced viral suppression.
    Akinsiku OT; Bansal A; Sabbaj S; Heath SL; Goepfert PA
    J Acquir Immune Defic Syndr; 2011 Oct; 58(2):132-40. PubMed ID: 21637109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTLV-II down-regulates HIV-1 replication in IL-2-stimulated primary PBMC of coinfected individuals through expression of MIP-1alpha.
    Casoli C; Vicenzi E; Cimarelli A; Magnani G; Ciancianaini P; Cattaneo E; Dall'Aglio P; Poli G; Bertazzoni U
    Blood; 2000 May; 95(9):2760-9. PubMed ID: 10779418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
    Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.
    Rallón NI; Soriano V; Restrepo C; García-Samaniego J; Labarga P; López M; Peris A; González-Lahoz J; Benito JM
    J Acquir Immune Defic Syndr; 2011 May; 57(1):1-8. PubMed ID: 21786458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
    Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proportion of CD57+ cells among effector CD8+ T cells is lower in HIV controllers compared with antiretroviral therapy-treated patients.
    Henriquez S; Lécuroux C; Bitu M; Avettand-Fenoel V; Churaqui F; Catalan P; Chéret A; Boufassa F; Saez-Cirion A; Monceaux V; Meyer L; Goujard C; Lambotte O; Bourgeois C;
    AIDS; 2019 Nov; 33(14):2137-2147. PubMed ID: 31688039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell level response of HIV-specific and cytomegalovirus-specific CD4 T cells correlate with viral control in chronic HIV-1 subtype A infection.
    Eller MA; Eller LA; Ratto-Kim S; Ouma BJ; Lo V; de Souza M; Guwatudde D; Nails B; Michael NL; Wabwire-Mangen F; Robb ML; Marovich MA; Sandberg JK; Currier JR
    J Acquir Immune Defic Syndr; 2012 Sep; 61(1):9-18. PubMed ID: 22580564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo functional analysis, expansion and adoptive transfer of cytomegalovirus-specific T-cells in patients with glioblastoma multiforme.
    Crough T; Beagley L; Smith C; Jones L; Walker DG; Khanna R
    Immunol Cell Biol; 2012 Oct; 90(9):872-80. PubMed ID: 22508289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of HIV on CD8+ T cell CD57 expression is distinct from that of CMV and aging.
    Lee SA; Sinclair E; Hatano H; Hsue PY; Epling L; Hecht FM; Bangsberg DR; Martin JN; McCune JM; Deeks SG; Hunt PW
    PLoS One; 2014; 9(2):e89444. PubMed ID: 24586783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granule-dependent mechanisms of lysis are defective in CD8 T cells of HIV-infected, antiretroviral therapy-treated individuals.
    Trabattoni D; Piconi S; Biasin M; Rizzardini G; Migliorino M; Seminari E; Boasso A; Piacentini L; Villa ML; Maserati R; Clerici M
    AIDS; 2004 Apr; 18(6):859-69. PubMed ID: 15060433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+ T-cell-mediated suppression of HIV replication in the first year of life: association with lower viral load and favorable early survival.
    Pollack H; Zhan MX; Safrit JT; Chen SH; Rochford G; Tao PZ; Koup R; Krasinski K; Borkowsky W
    AIDS; 1997 Jan; 11(1):F9-13. PubMed ID: 9110069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnitude and complexity of rectal mucosa HIV-1-specific CD8+ T-cell responses during chronic infection reflect clinical status.
    Critchfield JW; Young DH; Hayes TL; Braun JV; Garcia JC; Pollard RB; Shacklett BL
    PLoS One; 2008; 3(10):e3577. PubMed ID: 18974782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing CD8
    Warren JA; Clutton G; Goonetilleke N
    Front Immunol; 2019; 10():291. PubMed ID: 30863403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expansion ability but not the quality of HIV-specific CD8(+) T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors.
    López M; Peris A; Soriano V; Lozano S; Vicario JL; Rallón NI; Restrepo C; Benito JM
    Immunology; 2011 Nov; 134(3):305-13. PubMed ID: 21978000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication.
    Alatrakchi N; Duvivier C; Costagliola D; Samri A; Marcelin AG; Kamkamidze G; Astriti M; Agher R; Calvez V; Autran B; Katlama C
    AIDS; 2005 Jan; 19(1):25-33. PubMed ID: 15627030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifactorial nature of noncytolytic CD8+ T cell-mediated suppression of HIV replication: beta-chemokine-dependent and -independent effects.
    Rubbert A; Weissman D; Combadiere C; Pettrone KA; Daucher JA; Murphy PM; Fauci AS
    AIDS Res Hum Retroviruses; 1997 Jan; 13(1):63-9. PubMed ID: 8989428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring inhibition of HIV replication by ex vivo CD8⁺ T cells.
    Slichter CK; Friedrich DP; Smith RJ; Walsh PN; Mize G; Czartoski JL; McElrath MJ; Frahm N
    J Immunol Methods; 2014 Feb; 404():71-80. PubMed ID: 24374374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid (CSF) CD8+ T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND).
    Schrier RD; Hong S; Crescini M; Ellis R; Pérez-Santiago J; Spina C; Letendre S;
    PLoS One; 2015; 10(2):e0116526. PubMed ID: 25719800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
    Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
    J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.